A Comparison of Drug Eluting and Bare Metal Stents with Bivalirudin during PCI or Bivalirudin for 4 hours in Acute Coronary Syndromes. The Eindhoven Reperfusion Study

Trial Profile

A Comparison of Drug Eluting and Bare Metal Stents with Bivalirudin during PCI or Bivalirudin for 4 hours in Acute Coronary Syndromes. The Eindhoven Reperfusion Study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Jun 2011

At a glance

  • Drugs Bivalirudin (Primary) ; Everolimus (Primary)
  • Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis; Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms DEBATER-2
  • Most Recent Events

    • 25 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top